Each of the three players in NEAT1/miR-133b/TIMM17A axis may become a novel therapeutic target for the treatment of breast cancer, which is of crucial significance for the clinical prevention and diagnosis of breast cancer. The gene discussed is TIMM17A; the disease is breast carcinoma.